Jon Cuthbert

Jaguar Health (NASDAQ:JAGX), a commercial-stage pharmaceutical company focused on gastrointestinal products, released its consolidated financial results for the fourth quarter and full year ended December 31, 2025, on April 7, 2026.

Booz Allen Hamilton (NYSE:BAH) announced on April 7, 2026, the successful completion of its acquisition of Defy Security, a move aimed at consolidating its position as a dominant provider of high-speed, tech-enabled cybersecurity services for both commercial and government sectors.

Artivion (NYSE:AORT), a leading cardiac and vascular surgery company, announced on April 7, 2026, that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the NEXUS™ Aortic Arch System.

Ascendis Pharma (NASDAQ:ASND) has officially commenced the commercial launch of YUVIWEL® (navepegritide) in the United States, marking the availability of the first once-weekly treatment for pediatric patients with achondroplasia.

Telix Pharmaceuticals (NASDAQ:TLX), a global leader in radiopharmaceutical precision medicine, has reported Q1 2026 group revenue of $230 million, representing a 24% increase over the same period last year and an 11% sequential rise from the previous quarter.

Worldcoin fell to around $0.24 after a New Yorker investigation raised fresh concerns about founder Sam Altman’s credibility.

The US Securities and Exchange Commission has advanced its crypto market safe harbor proposal to the White House for regulatory review, marking a key step toward potential new rules.

Tech investor Marc Andreessen said artificial intelligence will trigger a “massive jobs boom,” rejecting concerns about widespread job losses as “all fake.”

Polymarket is rolling out its largest upgrade to date, introducing a new order book, upgraded smart contracts and a native stablecoin to improve trading performance.

World Liberty Financial has partnered with Aster DEX to integrate its USD1 stablecoin as the settlement asset for perpetual contracts on the platform.